Effects of cysteine on the pharmacokinetics of itraconazole in rats with protein-calorie malnutrition

Biopharmaceutics and Drug Disposition

Volumn 24, Issue 2, 2003, Pages 63-70

  Lee, Ae K ^a   Ahn, Choong Y ^a   Kim, Eun J ^a   Kwon, Jong W ^b   Kim, Sang G ^a   Chung, Suk J ^a   Shim, Chang K ^a   Lee, Myung G ^a  

^a Seoul National University   (South Korea)

^b Dong A Pharmaceutical Company   (South Korea)

Author keywords

CYP3A23; Cysteine; Itraconazole; PCM; Pharmacokinetics; Rats

Indexed keywords

CASEIN; CYSTEINE; CYTOCHROME P450 3A; CYTOCHROME P450 3A4; DRUG METABOLITE; HYDROXYITRACONAZOLE; ITRACONAZOLE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG BLOOD LEVEL; DRUG METABOLISM; LIVER MICROSOME; MALE; NONHUMAN; PROTEIN CALORIE MALNUTRITION; PROTEIN DIET; RAT; SEQUENCE HOMOLOGY;

ADMINISTRATION, ORAL; ANIMALS; ANTIFUNGAL AGENTS; AREA UNDER CURVE; ARYL HYDROCARBON HYDROXYLASES; CYSTEINE; DRUG INTERACTIONS; INJECTIONS, INTRAVENOUS; ITRACONAZOLE; MALE; PROTEIN-ENERGY MALNUTRITION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0037342085     PISSN: 01422782     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdd.337     Document Type: Article

References (21)

1. Thummel KE, Shen DD. Design and optimization of dosage regimens: Pharmacokinetic data. In Goodman & Gilman's The Pharmacological Basis of Therapeutics, Hardman JG, Limbird LE, Gilman AG (eds). McGraw-Hill, Medical Publishing Division: New York, 2001; 1972.
2. Yoo SD, Kang E, Jun H, Shin BS, Lee KC, Lee KH. Absorption, first-pass metabolism, and disposition of itraconazole in rats. Chem Pharm Bull 2000; 48: 798-801.
3. Cho MK, Kim YG, Lee MG, Kim SG. Suppression of rat hepatic cytochrome P450s by protein-calorie malnutrition: Complete or partial restoration by cysteine or methionine supplementation. Arch Biochem Biophys 1999; 372: 150-158.
4. Kim YG, Cho MK, Kwon JW, Kim SG, Kim SH, Lee MG. Effects of cysteine on the pharmacokinetics and pharmacodynamics of intravenous and oral azosemide in rats with protein-calorie malnutrition. Life Sci 2001; 68: 2329-2345.
5. Kim YG, Cho MK, Kwon JW, Kim SG, Lee MG. Effects of cysteine on the pharmacokinetics of intravenous adriamycin in rats with protein-calorie malnutrition. Res Commun Mol Pathol Pharmacol 2000; 107: 361-376.
6. Kim YG, Cho MK, Kwon JW, et al. Effects of cysteine on the pharmacokinetics of intravenous chlorzoxazone in rats with protein-calorie malnutrition. Biopharm Drug Dispos 2002; 23: 121-129.
7. Penzak SR, Gubbins PO, Gurley BJ, Wang PL, Saccente M. Grapefruit juice decreases the systemic availability of itraconazole capsules in healthy volunteers. Ther Drug Monitor 1999; 21: 304-309.
8. Janssen Pharmaceutica and Research Foundation, Janssen One-to-One Customer Action Center, Janssen Pharmaceutica Products, LR, April, 2001; 1.
9. Lewis DFV. P450 Substrate specificity and metabolism. In Cytochromes P450 Structure, Function and Mechanism. Talyor & Francis: Bristol, PA, 1996; 123.
10. Benito López P, Gálvez Moreno MA, Corpas Jiménez MS, Calañas Continente A. Influence of nutritional status on the organism's response to infectious disease. Rev Clin Esp 1993; 193: 255-260.
11. Stein DK, Sugar AM. Fungal infections in the immunocompromised host. Diagn Microbiol Infect Dis 1989; 12: 221S-228S.
12. Allenmark S, Touw DJ, de Goede PNFC. Rapid method of the analysis of itracoanzole and hydroxyitraconazole in serum by high-performance liquid chromatography. J Chromatogr 1990; 523: 203-206.
13. Chiou WL. Critical evaluation of potential error in pharmacokinetic studies using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve. J Pharmacokin Biopharm 1978; 6: 539-546.
14. Gibaldi M, Perrier D. Pharmacokinetics (2nd edn), Dekker: New York, 1982.
15. Kim SH, Choi YM, Lee MG. Pharmacokinetics and pharmacodynamics of furosemide in protein-calorie malnutrition. J Pharmacokin Biopharm 1993; 21: 1-17.
16. Chiou WL. New calculation method of mean total body clearance of drugs and its application to dosage regimens. J Pharm Sci 1980; 69: 90-91.
17. Chiou WL. New calculation method of mean apparent drug volume of distribution and application to rational dosage regimen. J Pharm Sci 1979; 68: 1067-1069.
18. Eatman FB, Colburn WA, Boxenbaum HG, et al. Pharmacokinetics of diazepam following multiple dose oral administration to healthy human subjects. J Pharmacokin Biopharm 1977; 5: 481-494.
19. Yamano K, Yamamoto K, Kotaki H, Sawada Y, Iga T. Quantitative prediction of metabolic inhibition of midazolam by itraconazole and ketoconazole in rats: implication of concentrative uptake of inhibitors into liver. Drug Metab Dispos 1999; 27: 395-402.
20. Davies B, Morris T. Physiological parameters in laboratory animals and humans. Pharm Res 1993; 10: 1093-1095.
21. Mitruka BM, Rawnsley HM. Clinical Biochemical and Hematological Reference Values in Normal Experimental Animals and Normal Humans (2nd edn), Masson Publishing USA Inc: New York, 1981.